119 related articles for article (PubMed ID: 18240156)
1. Mechanism of decrease of oral bioavailability of cyclosporin A during immunotherapy upon coadministration of amphotericin B.
Ishizaki J; Ito S; Jin M; Shimada T; Ishigaki T; Harasawa Y; Yokogawa K; Takami A; Nakao S; Miyamoto K
Biopharm Drug Dispos; 2008 May; 29(4):195-203. PubMed ID: 18240156
[TBL] [Abstract][Full Text] [Related]
2. Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats.
Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
J Pharm Pharmacol; 2004 Oct; 56(10):1259-66. PubMed ID: 15482640
[TBL] [Abstract][Full Text] [Related]
3. Long-term levothyroxine treatment decreases the oral bioavailability of cyclosporin A by inducing P-glycoprotein in small intestine.
Jin M; Shimada T; Shintani M; Yokogawa K; Nomura M; Miyamoto K
Drug Metab Pharmacokinet; 2005 Oct; 20(5):324-30. PubMed ID: 16272749
[TBL] [Abstract][Full Text] [Related]
4. Influence of cytarabine and cyclophosphamide on the disposition kinetics of cyclosporin A after bone marrow transplantation.
Shimada T; Aoki Y; Yokogawa K; Nomura M; Ishizaki J; Nishigami J; Miyamoto K
Transpl Int; 2003 Nov; 16(11):788-93. PubMed ID: 12844214
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis.
Ieiri I; Nakayama J; Murakami H; Hori Y; Higuchi S
Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088
[TBL] [Abstract][Full Text] [Related]
6. Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats.
Yang CY; Chao PD; Hou YC; Tsai SY; Wen KC; Hsiu SL
Food Chem Toxicol; 2006 Sep; 44(9):1572-8. PubMed ID: 16762474
[TBL] [Abstract][Full Text] [Related]
7. Modulation of mdr1a and CYP3A gene expression in the intestine and liver as possible cause of changes in the cyclosporin A disposition kinetics by dexamethasone.
Yokogawa K; Shimada T; Higashi Y; Itoh Y; Masue T; Ishizaki J; Asahi M; Miyamoto K
Biochem Pharmacol; 2002 Feb; 63(4):777-83. PubMed ID: 11992648
[TBL] [Abstract][Full Text] [Related]
8. Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone.
Jin M; Shimada T; Yokogawa K; Nomura M; Kato Y; Tsuji A; Miyamoto K
Int J Pharm; 2006 Feb; 309(1-2):81-6. PubMed ID: 16384676
[TBL] [Abstract][Full Text] [Related]
9. Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide.
Cárcel-Trullols J; Torres-Molina F; Araico A; Saadeddin A; Peris JE
Cancer Chemother Pharmacol; 2004 Aug; 54(2):153-60. PubMed ID: 15114410
[TBL] [Abstract][Full Text] [Related]
10. S-adenosylmethionine protects against intrabiliary glutathione degradation induced by long-term administration of cyclosporin A in the rat.
Palomero J; Galán AI; Muñoz ME; González-Gallego J; Tuñón MJ; Jiménez R
Toxicology; 2004 Sep; 201(1-3):239-45. PubMed ID: 15297037
[TBL] [Abstract][Full Text] [Related]
11. Effects of S-adenosylmethionine on intrabiliary glutathione degradation induced by long-term administration of cyclosporin A in the rat.
Palomero J; Galán AI; Muñoz ME; González-Gallego J; Tuñón MJ; Jiménez R
Toxicology; 2004 Jul; 200(1):21-7. PubMed ID: 15158560
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of cyclosporine A after massive hepatectomy: a hint for small-for-size graft in living donor liver transplantation.
Shinohara H; Shimada M; Ogasawara T; Morine Y; Ikemoto T; Imura S; Fujii M
Dig Dis Sci; 2007 Oct; 52(10):2490-6. PubMed ID: 17431772
[TBL] [Abstract][Full Text] [Related]
13. Effect of gonadectomy on cyclosporine pharmacokinetics in male and female rats.
Molpeceres J; Chacón M; Aberturas MR; Guzmán M; Díez ML; Rodriguez-Puyol M
Pharmazie; 2001 Jan; 56(1):78-82. PubMed ID: 11210676
[TBL] [Abstract][Full Text] [Related]
14. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M
J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703
[TBL] [Abstract][Full Text] [Related]
15. Metabolism for cyclosporin A during liver regeneration after partial hepatectomy in rats.
Nagayoshi S; Kawashita Y; Eguchi S; Kamohara Y; Takatsuki M; Miyamoto S; Mochizuki S; Soyama A; Tokai H; Hidaka M; Tajima Y; Kanematsu T
World J Gastroenterol; 2008 Nov; 14(41):6355-9. PubMed ID: 19009651
[TBL] [Abstract][Full Text] [Related]
16. [Relative bioavailability of cyclosporine A-loaded hydroxypropyl methylcellulose phthalate nanoparticles for oral administration in rats].
Wang XQ; Dai JD; Zhang Q; Zhang T; Xia GM
Yao Xue Xue Bao; 2004 Jun; 39(6):463-6. PubMed ID: 15491107
[TBL] [Abstract][Full Text] [Related]
17. In vivo induction of hepatic p-glycoprotein by cyclosporine in the rat.
Bai S; Liu J; Lu SK; Brunner LJ
Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):103-14. PubMed ID: 11458978
[TBL] [Abstract][Full Text] [Related]
18. Effect of atropine on gastrointestinal motility and the bioavailability of cyclosporine A in rats.
Quijano RF; Ohnishi N; Umeda K; Komada F; Iwakawa S; Okumura K
Drug Metab Dispos; 1993; 21(1):141-3. PubMed ID: 8095208
[TBL] [Abstract][Full Text] [Related]
19. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A.
Dai J; Nagai T; Wang X; Zhang T; Meng M; Zhang Q
Int J Pharm; 2004 Aug; 280(1-2):229-40. PubMed ID: 15265562
[TBL] [Abstract][Full Text] [Related]
20. Effect of imatinib mesilate on the disposition kinetics of ciclosporin in rats.
Kajita T; Higashi Y; Imamura M; Maida C; Fujii Y; Yamamoto I; Miyamoto E
J Pharm Pharmacol; 2006 Jul; 58(7):997-1000. PubMed ID: 16805961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]